Literature DB >> 23374739

Normocalcemic primary hyperparathyroidism.

Natalie E Cusano1, Shonni J Silverberg, John P Bilezikian.   

Abstract

Primary hyperparathyroidism, a common endocrine disorder, is traditionally defined by hypercalcemia and elevated levels of parathyroid hormone (PTH). A newer presentation of primary hyperparathyroidism has been described over the past decade, in which PTH is elevated but serum calcium is consistently normal, in the absence of secondary causes of hyperparathyroidism, such as renal disease or vitamin D deficiency. Recognition of this phenotype of primary hyperparathyroidism, normocalcemic primary hyperparathyroidism, supports a biphasic chronological time course in some individuals in which PTH levels are first elevated but serum calcium is normal, followed by the development of frank hypercalcemia. This review focuses on the available literature regarding this newly described phenotype of primary hyperparathyroidism.
Copyright © 2013 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374739      PMCID: PMC3564219          DOI: 10.1016/j.jocd.2012.12.001

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  29 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

3.  Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume.

Authors:  L E Mallette; K Khouri; H Zengotita; B W Hollis; S Malini
Journal:  J Clin Endocrinol Metab       Date:  1989-03       Impact factor: 5.958

4.  Treatment with with oestrogens of primary hyperparathyroidism in post-menopausal women.

Authors:  J C Gallagher; B E Nordin
Journal:  Lancet       Date:  1972-03-04       Impact factor: 79.321

5.  Effect of renal function on skeletal health in primary hyperparathyroidism.

Authors:  Marcella D Walker; David W Dempster; Donald J McMahon; Julia Udesky; Elizabeth Shane; John P Bilezikian; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

6.  Bone loss in celiac disease is related to secondary hyperparathyroidism.

Authors:  P L Selby; M Davies; J E Adams; E B Mawer
Journal:  J Bone Miner Res       Date:  1999-04       Impact factor: 6.741

7.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

8.  Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism.

Authors:  Ilkay Cakir; Kursad Unluhizarci; Fatih Tanriverdi; Gulsah Elbuken; Zuleyha Karaca; Fahrettin Kelestimur
Journal:  Endocrine       Date:  2012-02-12       Impact factor: 3.633

9.  Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Assessment by use of biochemical markers.

Authors:  F Cosman; V Shen; F Xie; M Seibel; A Ratcliffe; R Lindsay
Journal:  Ann Intern Med       Date:  1993-03-01       Impact factor: 25.391

10.  Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: More Stone than Bone?

Authors:  L M Amaral; D C Queiroz; T F Marques; M Mendes; F Bandeira
Journal:  J Osteoporos       Date:  2012-03-25
View more
  42 in total

1.  Primary Hyperparathyroidism: A Tale of Two Cities Revisited - New York and Shanghai.

Authors:  Jian-Min Liu; Natalie E Cusano; Barbara C Silva; Lin Zhao; Xiao-Yan He; Bei Tao; Li-Hao Sun; Hong-Yan Zhao; Wen-Wei Fan; Megan E Romano; Guang Ning; John P Bilezikian
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 2.  Mild primary hyperparathyroidism: a literature review.

Authors:  Megan K Applewhite; David F Schneider
Journal:  Oncologist       Date:  2014-07-25

3.  Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

Authors:  Jose Luis Perez Castrillón; Gonzalo Díaz-Soto; Olatz Izaola Jauregui; Enrique Romero; Daniel de Luis Román
Journal:  Endocrine       Date:  2015-04-21       Impact factor: 3.633

4.  Prevalence of primary hyperparathyroidism in a referred sample of fibromyalgia patients.

Authors:  Robert Ferrari; Anthony Science Russell
Journal:  Clin Rheumatol       Date:  2014-07-03       Impact factor: 2.980

5.  Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice.

Authors:  Anamika Singh; Masum M Mia; Dasan Mary Cibi; Ashutosh Kumar Arya; Sanjay Kumar Bhadada; Manvendra K Singh
Journal:  J Biol Chem       Date:  2019-04-12       Impact factor: 5.157

Review 6.  Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.

Authors:  Joaquín Gómez-Ramírez; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2017-08-19       Impact factor: 3.445

7.  Polymorphisms of CASR gene increase the risk of primary hyperparathyroidism.

Authors:  X-M Wang; Y-W Wu; Z-J Li; X-H Zhao; S-M Lv; X-H Wang
Journal:  J Endocrinol Invest       Date:  2015-12-28       Impact factor: 4.256

8.  Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?

Authors:  Emanuela Traini; Rocco Bellantone; Serena Elisa Tempera; Salvatore Russo; Carmela De Crea; Celestino Pio Lombardi; Marco Raffaelli
Journal:  Langenbecks Arch Surg       Date:  2018-03-14       Impact factor: 3.445

9.  Actual role of color-doppler high-resolution neck ultrasonography in primary hyperparathyroidism: a clinical review and an observational study with a comparison of 99mTc-sestamibi parathyroid scintigraphy.

Authors:  Giovanni Mariano Vitetta; Alberto Ravera; Giovanni Mensa; Luca Fuso; Pierluigi Neri; Alessandro Carriero; Stefano Cirillo
Journal:  J Ultrasound       Date:  2018-10-24

Review 10.  Asymptomatic primary hyperparathyroidism.

Authors:  Shonni J Silverberg; Marcella D Walker; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.